| # | Drug | Count |
|---|---|---|
| 0 | CYCLOSPORINE | 61 |
| 1 | TACROLIMUS | 43 |
| 2 | ECULIZUMAB | 39 |
| 3 | METHYLPREDNISOLONE | 32 |
| 4 | CYCLOPHOSPHAMIDE | 31 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 31 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 31 |
| 7 | METHOTREXATE SODIUM | 31 |
| 8 | METHOTREXATE | 30 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAZIQUANTEL | 4 | 0.0132 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 8 | 0.0035 |
| 2 | CEFOTAXIME INJECTION | 9 | 0.0021 |
| 3 | FLUTAMIDE | 2 | 0.0020 |
| 4 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 16 | 0.0019 |
| 6 | CAPLACIZUMAB | 3 | 0.0017 |
| 7 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 8 | DINUTUXIMAB | 1 | 0.0012 |
| 9 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 72 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 61 |
| 2 | Complement Inhibitor [EPC] | 40 |
| 3 | Alkylating Drug [EPC] | 35 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 30 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 27 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 7 | Loop Diuretic [EPC] | 20 |
| 8 | Azole Antifungal [EPC] | 19 |
| 9 | Platinum-based Drug [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 4 | 0.0014 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 4 | 0.0010 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 4 | Complement Inhibitor [EPC] | 40 | 0.0007 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 15 | 0.0007 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 61 | 0.0005 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 6 | 0.0005 |
| 8 | Gonadotropin [EPC] | 1 | 0.0005 |
| 9 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |